BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Yan Xu, Aditi Sharma, Yang Chen, Honghui Zhou. What We Can Learn from Current Inflammatory Bowel Disease (IBD) Biological Therapy—Dose Regimen and OthersCurrent Pharmacology Reports 2019; 5(3): 115 doi: 10.1007/s40495-019-00180-x
2
Yan Xu, Chuanpu Hu, Yang Chen, Xin Miao, Omoniyi J. Adedokun, Zhenhua Xu, Amarnath Sharma, Honghui Zhou. Population Pharmacokinetics and Exposure‐Response Modeling Analyses of Ustekinumab in Adults With Moderately to Severely Active Ulcerative ColitisThe Journal of Clinical Pharmacology 2020;  doi: 10.1002/jcph.1582
3
Michel Adamina, Stefanos Bonovas, Tim Raine, Antonino Spinelli, Janindra Warusavitarne, Alessandro Armuzzi, Oliver Bachmann, Palle Bager, Livia Biancone, Bernd Bokemeyer, Peter Bossuyt, Johan Burisch, Paul Collins, Glen Doherty, Alaa El-Hussuna, Pierre Ellul, Gionata Fiorino, Cornelia Frei-Lanter, Federica Furfaro, Christian Gingert, Paolo Gionchetti, Javier P Gisbert, Fernando Gomollon, Marien González Lorenzo, Hannah Gordon, Tibor Hlavaty, Pascal Juillerat, Konstantinos Katsanos, Uri Kopylov, Eduards Krustins, Torsten Kucharzik, Theodore Lytras, Christian Maaser, Fernando Magro, John Kenneth Marshall, Pär Myrelid, Gianluca Pellino, Isadora Rosa, Joao Sabino, Edoardo Savarino, Laurents Stassen, Joana Torres, Mathieu Uzzan, Stephan Vavricka, Bram Verstockt, Oded Zmora. ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical TreatmentJournal of Crohn's and Colitis 2020; 14(2): 155 doi: 10.1093/ecco-jcc/jjz187
4
Tushar Shukla, Bruce E. Sands. Novel Non-biologic Targets for Inflammatory Bowel DiseaseCurrent Gastroenterology Reports 2019; 21(5) doi: 10.1007/s11894-019-0689-2
5
Irene Marafini, Silvia Sedda, Vincenzo Dinallo, Giovanni Monteleone. Inflammatory cytokines: from discoveries to therapies in IBDExpert Opinion on Biological Therapy 2019; 19(11): 1207 doi: 10.1080/14712598.2019.1652267
6
Peter Kienle. Impact of Modern Drug Therapy on Surgery: Crohn's DiseaseVisceral Medicine 2018; 34(6): 422 doi: 10.1159/000495127
7
Nicole L. Mancini, Luke Goudie, Warren Xu, Rasha Sabouny, Sruthi Rajeev, Arthur Wang, Nicolas Esquerre, Ala Al Rajabi, Timothy S. Jayme, Erik van Tilburg Bernandes, Yasmin Nasser, José G.P. Ferraz, Timothy Shutt, Jane Shearer, Derek M. McKay. Perturbed Mitochondrial Dynamics Is a Novel Feature of Colitis That Can Be Targeted to Lessen DiseaseCellular and Molecular Gastroenterology and Hepatology 2020;  doi: 10.1016/j.jcmgh.2020.04.004
8
Boris Gole, Uroš Potočnik. Pre-Treatment Biomarkers of Anti-Tumour Necrosis Factor Therapy Response in Crohn’s Disease—A Systematic Review and Gene Ontology AnalysisCells 2019; 8(6): 515 doi: 10.3390/cells8060515
9
Sara Salvador-Martín, Beatriz López-Cauce, Olga Nuñez, Emilio J. Laserna-Mendieta, María I. García, Elena Lobato, Judith Abarca-Zabalía, María Sanjurjo-Saez, Alfredo J. Lucendo, Ignacio Marín-Jiménez, Luis A. Menchén, Luis A. López-Fernández. Genetic predictors of long-term response and trough levels of infliximab in crohn’s diseasePharmacological Research 2019; 149: 104478 doi: 10.1016/j.phrs.2019.104478
10
Ciro Romano, Sergio Esposito, Roberta Ferrara, Giovanna Cuomo. Choosing the most appropriate biologic therapy for Crohn’s disease according to concomitant extra-intestinal manifestations, comorbidities, or physiologic conditionsExpert Opinion on Biological Therapy 2020; 20(1): 49 doi: 10.1080/14712598.2020.1689953
11
Elena Milanesi, Maria Dobre, Teodora E. Manuc, Gabriel Becheanu, Cristian G. Tieranu, Elena M. Ionescu, Mircea Manuc. Mucosal gene expression changes induced by anti‐TNF treatment in inflammatory bowel disease patientsDrug Development Research 2019; 80(6): 831 doi: 10.1002/ddr.21566
12
Balaji Venkataraman, Shreesh Ojha, Prasanna D. Belur, Bhoomendra Bhongade, Vishnu Raj, Peter D. Collin, Thomas E. Adrian, Sandeep B. Subramanya. Phytochemical drug candidates for the modulation of peroxisome proliferator‐activated receptor γ in inflammatory bowel diseasesPhytotherapy Research 2020;  doi: 10.1002/ptr.6625
13
Stuart Bloom, Tariq Iqbal, Chuka Nwokolo, Vipul Jairath, Jesse Hall, Bruce Dzyngel, Peter Gardzinski. A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of a Targeted Release Oral Cyclosporine Formulation in the Treatment of Mild to Moderate Ulcerative Colitis: Influence of Immunosuppressants at BaselineAmerican Journal of Gastroenterology 2019; 114: S419 doi: 10.14309/01.ajg.0000592388.53875.b2
14
Cindy CY Law, Deborah Koh, Yueyang Bao, Vipul Jairath, Neeraj Narula. Risk of postoperative infectious complications from medical therapies in inflammatory bowel diseaseCochrane Database of Systematic Reviews 2019;  doi: 10.1002/14651858.CD013256
15
Pharmacokinetic Profiling and Simultaneous Determination of Thiopurine Immunosuppressants and Folic Acid by Chromatographic MethodsMolecules 2019; 24(19): 3469 doi: 10.3390/molecules24193469
16
Simon P. Borg-Bartolo, Ray Kiran Boyapati, Jack Satsangi, Rahul Kalla. Precision medicine in inflammatory bowel disease: concept, progress and challengesF1000Research 2020; 9: 54 doi: 10.12688/f1000research.20928.1
17
Young-Jae Hwang, Seung-Joo Nam, Wanjoo Chun, Song In Kim, Sung Chul Park, Chang Don Kang, Sung Joon Lee, Partha Mukhopadhyay. Anti-inflammatory effects of apocynin on dextran sulfate sodium-induced mouse colitis modelPLOS ONE 2019; 14(5): e0217642 doi: 10.1371/journal.pone.0217642